Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameTUPOS LV/ATX & KRONOS LV-T CRT-D & COROX OWT STEROID LV PACING LEAD
Classification Namedefibrillator, implantable, dual-chamber
ApplicantBIOTRONIK, INC.
PMA NumberP050023
Date Received07/11/2005
Decision Date08/10/2006
Product Code
MRM[ Registered Establishments with MRM ]
Docket Number 06M-0367
Notice Date 09/08/2006
Advisory Committee Cardiovascular
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for the tupos lv/atx crt-d, kronos lv-t crt-d, 505. U programmer software for the ics 3000, a-k00. 7. U programmer software for the epr/tms 1000plus and corox otw steroid lead. The tupos lv/atx and kronos lv-t crt-ds are indicated for use in patients with all of the following conditions: 1) indicated for icd therapy; 2) receiving optimized and stable congestive heart failure (chf) drug therapy; 3) symptomatic chf (nyha class iii/iv and lvef <=35%); and 4) intraventricular conduction delay (qrs duration >=130 ms). The tupos lv/atx is also indicated for patients who, in addition to an indication for a crt-d device, have atrial tachyarrhythmias or are at risk of developing atrial tachyarrhythmias. The corox otw steroid leads are intended for implantation via the coronary veins to provide long term cardiac pacing when used in conjunction with a compatible pulse generator.
Approval Order Approval Order
Post-Approval StudyShow Report Schedule and Study Progress
Supplements: S001 S002 S003 S005 S006 S007 
S008 S009 S010 S011 S012 S013 
S014 S015 S016 S017 S018 S019 
S020 S021 S022 S023 S024 S026 
S027 S028 S029 S030 S031 S032 
S033 S034 S035 S036 S037 S038 
S039 S040 S041 S043 S044 S045 
S046 S047 S048 S049 S050 S051 
S052 S053 S054 S055 S056 S057 
S058 S059 S060 S061 S063 
-
-